Letters
Few university students from overseas have been vaccinated against meningococcal infection
BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7278.102 (Published 13 January 2001) Cite this as: BMJ 2001;322:102
- Matthew R Edmunds, 4th year medical student,
- James E Davison, 4th year medical student,
- Annette L Wood (annette.wood@hq.birminghamha.wmids.nhs.uk), consultant in communicable disease control,
- Vijay Raichura, medical officer
- University of Birmingham, Birmingham B15 2TT
- Birmingham Health Authority, Birmingham B16 9RG
- University of Birmingham, Health Centre, Birmingham B15 2SE
EDITOR—It is now a year since the new conjugated meningococcal group C vaccine was introduced to the United Kingdom.1 Students in higher education are at a higher risk of meningococcal disease than other students and were targeted in the government vaccination campaign. Because of the limited supply and late licensing of the new vaccine the pre-existing polysaccharide vaccine was used.
To determine the effect of the policy we performed a cross sectional study of 3028 first year undergraduate and overseas postgraduate students …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.